MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu-Chen, L. Y.
Right arrow Articles by Phillips, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu-Chen, L. Y.
Right arrow Articles by Phillips, C. A.

Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides

LY Liu-Chen, C Chen and CA Phillips

Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.

We previously showed that under defined conditions beta- [3H]funaltrexamine (beta-[3H]FNA) covalently labeled mu-opioid receptors with high specificity in bovine striatal membranes. beta- [3H]FNA-labeled mu-opioid receptors migrated as a broad band with a molecular mass range of 68-97 kDa. It is controversial whether beta-FNA binds irreversibly to mu-opioid receptors in other species. In this study, we demonstrated that beta-[3H]FNA also labeled mu-opioid receptors with high specificity in brain membranes of the guinea pig, rat, and mouse. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography revealed that in each species beta- [3H]FNA specifically bound to a protein in which labeling was greatly reduced by naloxone. These labeled receptors had broad molecular mass ranges, and the molecular masses were different among these species, in the order of cow > guinea pig > rat > mouse. Membranes were subjected to solubilization with 2% Triton X-100 and wheat germ lectin (WGL) affinity chromatography. N-Acetylglucosamine eluted a peak of radioactivity. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography showed that in all four species the mu receptor was the only protein labeled with beta-[3H]FNA in the WGL eluate. The molecular masses of labeled mu-opioid receptors were 70-88 kDa (median, 77 kDa) for the cow, 66-80 kDa (median, 72 kDa) for the guinea pig, 60-75 kDa (median, 67 kDa) for the rat, and 60-72 kDa (median, 66 kDa) for the mouse. In addition, we investigated the nature of the carbohydrate moieties linked to the receptor protein and whether the species variation in the molecular mass was due to variable degrees of glycosylation. The bovine WGL eluate was treated with various glycosidases. Neuraminidase treatment decreased the receptor molecular mass by 6-7 kDa, whereas alpha-mannosidase had no effect. Removal of N- linked carbohydrates at asparagine residues by peptide-N4-[N-acetyl- beta-glucosaminyl]asparagine amidase (N-Glycanase) resulted in a much sharper specifically labelled protein band of 43 kDa. These results indicate that mu-opioid receptors are heavily glycosylated and the major carbohydrate moieties are of the complex type, N-linked to asparagine. After the WGL eluates for the four species were treated with N-Glycanase, the labeled receptors became much sharper bands with very similar molecular masses, i.e., 43 kDa for the cow and guinea pig, 39 kDa for the rat, and and 40 kDa for the mouse.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 44, Issue 4, pp. 749-756, 10/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. Kim, A. L. Clark, A. Kiss, J. W. Hahn, R. Wesselschmidt, C. J. Coscia, and M. M. Belcheva
{micro}- and {kappa}-Opioids Induce the Differentiation of Embryonic Stem Cells to Neural Progenitors
J. Biol. Chem., November 3, 2006; 281(44): 33749 - 33760.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Chen, J.-G. Li, Y. Chen, P. Huang, Y. Wang, and L.-Y. Liu-Chen
GEC1 Interacts with the {kappa} Opioid Receptor and Enhances Expression of the Receptor
J. Biol. Chem., March 24, 2006; 281(12): 7983 - 7993.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Garzon, M. Rodriguez-Munoz, A. Lopez-Fando, and P. Sanchez-Blazquez
Activation of {micro}-Opioid Receptors Transfers Control of G{alpha} Subunits to the Regulator of G-protein Signaling RGS9-2: ROLE IN RECEPTOR DESENSITIZATION
J. Biol. Chem., March 11, 2005; 280(10): 8951 - 8960.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Sánchez-Blázquez, A. García-España, and J. Garzón
Antisense Oligodeoxynucleotides to Opioid Mu and Delta Receptors Reduced Morphine Dependence in Mice: Role of Delta-2 Opioid Receptors
J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1423 - 1431.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Chen, J. Yin, J. K. d. Riel, R. L. DesJarlais, L. F. Raveglia, J. Zhu, and L.-Y. Liu-Chen
Determination of the Amino Acid Residue Involved in [3H]beta -Funaltrexamine Covalent Binding in the Cloned RatµOpioid Receptor
J. Biol. Chem., August 30, 1996; 271(35): 21422 - 21429.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhu, J. Yin, P.-Y. Law, P. A. Claude, K. C. Rice, C. J. Evans, C. Chen, L. Yu, and L.-Y. Liu-Chen
Irreversible Binding of cis-(+)-3-Methylfentanyl Isothiocyanate to the [IMAGE] Opioid Receptor and Determination of Its Binding Domain
J. Biol. Chem., January 19, 1996; 271(3): 1430 - 1434.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Chen, J.-C. Xue, J. Zhu, Y.-W. Chen, S. Kunapuli, J. K. d. Riel, L. Yu, and L.-Y. Liu-Chen
Characterization of Irreversible Binding of [IMAGE]-Funaltrexamine to the Cloned Rat µ Opioid Receptor
J. Biol. Chem., July 28, 1995; 270(30): 17866 - 17870.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics